Multicentric Phase II Study of Concomitant Chemo-Radiotherapy in Locally Advanced Non Small Cell Lung Cancer, With :- Induction Chemotherapy by Cisplatin - Docetaxel- Concomitant Chemo-Radiotherapy by Weekly Cisplatin – Docetaxel- Consolidation Chemotherapy by Docetaxel.

Trial Profile

Multicentric Phase II Study of Concomitant Chemo-Radiotherapy in Locally Advanced Non Small Cell Lung Cancer, With :- Induction Chemotherapy by Cisplatin - Docetaxel- Concomitant Chemo-Radiotherapy by Weekly Cisplatin – Docetaxel- Consolidation Chemotherapy by Docetaxel.

Discontinued
Phase of Trial: Phase II

Latest Information Update: 25 Jul 2013

At a glance

  • Drugs Cisplatin; Docetaxel
  • Indications Non-small cell lung cancer
  • Focus Therapeutic Use
  • Most Recent Events

    • 23 Jan 2008 The expected completion date for this trial is now 1 Mar 2007.
    • 31 Oct 2007 Status changed from recruiting to discontinued
    • 20 Sep 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top